Drug interactions
Encorafenib + Triptorelin
Severity: Moderate
Encorafenib and Triptorelin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs can prolong the QT interval. Encorafenib prolongs QTc in a dose-dependent way, and triptorelin may add to this through androgen deprivation. The combination raises the risk of ventricular arrhythmia.
What this interaction means in plain words
Encorafenib and Triptorelin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Encorafenib belongs to Oncology; Triptorelin belongs to Endocrine.
Why it happens
Additive QT prolongation through different mechanisms.
What to do
Check ECG and electrolytes at baseline and periodically during therapy, and correct hypokalemia and hypomagnesemia. Reduce or interrupt encorafenib if QTc rises markedly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Triptorelin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Triptorelin
Other interactions of Encorafenib
Frequently asked questions
Can I take Encorafenib with Triptorelin?
MediHelp rates the interaction as moderate. Encorafenib and Triptorelin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval. Encorafenib prolongs QTc in a dose-dependent way, and triptorelin may add to this through androgen deprivation. The combination raises the risk of ventricular arrhythmia.
How serious is the interaction between Encorafenib and Triptorelin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG and electrolytes at baseline and periodically during therapy, and correct hypokalemia and hypomagnesemia. Reduce or interrupt encorafenib if QTc rises markedly.
What other medicines interact with Triptorelin?
MediHelp also lists interactions of Triptorelin with, for example, Amisulpride, Arsenic trioxide, Bedaquiline. The full list is on the Triptorelin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
